Schiele Thomas M, Rieber Johannes, König Andreas, Leibig Marcus, Erhard Isabelle, Theisen Karl, Siebert Uwe, Klauss Volker
Cardiology Division, Medizinische Poliklinik-Innenstadt, University of Munich, Munich, Germany.
Am J Cardiol. 2004 Oct 1;94(7):917-21. doi: 10.1016/j.amjcard.2004.06.028.
In-stent restenosis (ISR), especially after vascular brachytherapy, is a therapeutic challenge. Sirolimus-eluting stent implantation is a promising new option for the treatment of patients with ISR. The efficacy of sirolimus-eluting stent implantation for the treatment of patients with their first episodes of ISR and with recurrent ISR due to the failure of vascular brachytherapy was compared using intravascular ultrasound imaging.
支架内再狭窄(ISR),尤其是在血管近距离放射治疗后,是一个治疗挑战。西罗莫司洗脱支架植入是治疗ISR患者的一种有前景的新选择。使用血管内超声成像比较了西罗莫司洗脱支架植入治疗首次发作的ISR患者以及因血管近距离放射治疗失败导致的复发性ISR患者的疗效。